Skip to main content

Abstract

Diabetes is a heterogeneous disease with three main types: type 1, type 2, and latent autoimmune diabetes. The main condition that develops in type 2 diabetes is insulin resistance. In type 1 diabetes and LADA, lack of insulin production is the primary condition but one should be aware that many of these patients also develop a resistance to exogenous insulin if they become obese. It is generally well understood that any weight loss or improved dietary management can help to control diabetes. However, when these attempts prove ineffective, bariatric surgery is considered. This chapter reviews the current role of the Sleeve Gastrectomy in the treatment of obesity related diabetes. Concepts reviewed include diabetes outcomes by BMI, duration of diabetes, time to resolution, C-peptide production, Pouch/Bougie size, and comparison to other procedures. The heterogeneity of diabetes and the variations in sleeve gastrectomy technique make it difficult to analyze outcomes but many reasonable conclusions can be made.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76–9.

    Article  PubMed  Google Scholar 

  2. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–50.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Hess DS, Hess DW. Biliopancreatic diversion with a duodenal switch. Obes Surg. 1998;8(3):267–82.

    Article  PubMed  CAS  Google Scholar 

  4. Ren CJ. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg. 2000;10(6):514–23. discussion 524.

    Article  PubMed  CAS  Google Scholar 

  5. Lee CM. Vertical gastrectomy for morbid obesity in 216 patients: report of two-year results. Surg Endosc. 2007;21(10):1810–6.

    Article  PubMed  Google Scholar 

  6. Bellanger DE, Greenway FL. Laparoscopic sleeve gastrectomy, 529 cases without a leak: short term results and technical considerations. Obes Surg. 2011;21:146–50.

    Article  PubMed  Google Scholar 

  7. Mechanik JI, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity. 2013;21:S1–27.

    Article  CAS  Google Scholar 

  8. Langer FB, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;14:1024–9.

    Article  Google Scholar 

  9. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric Surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.

    Article  PubMed  CAS  Google Scholar 

  10. Brethauer A, Hammel JP, Schauer PR. Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis. 2009;5(4):469–75.

    Article  PubMed  Google Scholar 

  11. Gill RS, Sharma AM, Al-Adra DP, et al. The impact of bariatric surgery in patients with Type-2 diabetes mellitus. Curr Diabetes Rev. 2011;7:185–9.

    Article  PubMed  Google Scholar 

  12. Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Surg. 2006;16:1138–44.

    Article  PubMed  Google Scholar 

  13. Cottam D, Dureshi FG, Mattar SF, et al. Laparoscopic sleeve gastrectomy as an initial weight loss procedure for high-risk patients with morbid obesity. Surg Endosc. 2006;20:859–63.

    Article  PubMed  CAS  Google Scholar 

  14. Vidal J, Ibarzabal A, Romero F, et al. Type 2 diabetes mellitus and the metabolic syndrome following sleeve gastrectomy in severely obese subjects. Obes Surg. 2008;18:1077–82.

    Article  PubMed  CAS  Google Scholar 

  15. Kehagias I, Spyropoulos C, Karamanakos S, et al. Efficacy of sleeve gastrectomy as sole procedure in patients with clinical severe obesity. Surg Obes Relat Dis. 2013;9(3):363–9.

    Article  PubMed  Google Scholar 

  16. Menenkakos E, Stamou K, Albanoupoulos K, et al. Laparoscopic sleeve gastrectomy performed with intent to treat morbid obesity: a prospective single-center study of 261 patients with a median follow-up of 1 year. Obes Surg. 2010;20:276–82.

    Article  Google Scholar 

  17. Basso N, Casella G, Rizzello M. Laparoscopic sleeve gastrectomy as first stage or definitive intent in 300 consecutive cases. Surg Endosc. 2011;25:444–9.

    Article  PubMed  CAS  Google Scholar 

  18. Magee CJ, Barry J, Arumugasamy M. Laparoscopic sleeve gastrectomy for high-risk patients: weight loss and comorbidity improvement-short-term results. Obes Surg. 2011;21(5):547–50.

    Article  PubMed  Google Scholar 

  19. Abbatini F, Capoccia D, Basso N. Type 2 diabetes in obese patients with body mass index of 30-35 kg/m2: sleeve gastrectomy versus medical treatment. Surg Obes Relat Dis. 2012;8(1):20–4.

    Article  PubMed  Google Scholar 

  20. Atkins ER, Preen DB, Cohen LD. Improved obesity reduction and co-morbidity resolution in patients treated with 40 French bougie versus 50 French bougie four years after laparoscopic sleeve gastrectomy. Analysis of 294 patients. Obes Surg. 2012;22(1):97–104.

    Article  PubMed  Google Scholar 

  21. Spivak H, Moshe R, Sadot E. Laparoscopic sleeve gastrectomy using a 42-French versus a 32 French bougie: the first-year outcome. Obes Surg. 2014;24(7):1090–3.

    Article  PubMed  Google Scholar 

  22. Abdallah E, El Nakeeb A, Yousef T. Impact of extent of antral resection on surgical outcomes of sleeve gastrectomy for morbid obesity (A prospective randomized study). Obes Surg. 2014;24(10):1587–94.

    Article  PubMed  Google Scholar 

  23. Rizzello M, Abbatine F, Casella G. Early postoperative insulin-resistance changes after sleeve gastrectomy. Obes Surg. 2010;20(1):50–5.

    Article  PubMed  Google Scholar 

  24. Rosenthal R, Li X, Somstein S. Effect of sleeve gastrectomy on patients with diabetes mellitus. Surg Obes Relat Dis. 2009;5(4):429–34.

    Article  PubMed  Google Scholar 

  25. Casella G, Basso N. Ten-year duration of type 2 diabetes mellitus as a prognostic factor for remission after sleeve gastrectomy. Surg Obes Relat Dis. 2011;7:697–702.

    Article  PubMed  Google Scholar 

  26. Shah PS, Todkar JS, Shah SS. Effectiveness of laparoscopic sleeve gastrectomy on glycemic control in obese Indians with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6(2):138–41.

    Article  PubMed  Google Scholar 

  27. Slater BJ, Bellatorre N, Eisenberg D. Early postoperative outcomes and medication cost savings after laparoscopic sleeve gastrectomy in morbidly obese patients with type 2 diabetes. J Obes. 2011;2011:350523.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Todkar JS, Shah SS, Shah PS, et al. Long-term effects of laparoscopic sleeve gastrectomy in morbidly obese subjects with type 2 diabetes mellitus. Surg Obes Relat Dis. 2010;6(2):142–5.

    Article  PubMed  Google Scholar 

  29. Vidal J, Ibarzabal A, Lacy A. Short term effects of sleeve gastrectomy on type 2 diabetes mellitus in severely obese subjects. Obes Surg. 2007;17:1069–74.

    Article  PubMed  CAS  Google Scholar 

  30. Bayham BE, Greenway FL, Bellanger DE, et al. Early resolution of type 2 diabetes seen after Roux en Y gastric bypass and vertical sleeve gastrectomy. Diabetes Technol Ther. 2012;14(1):30–4.

    Article  PubMed  Google Scholar 

  31. Pham S, Gancel A, Scotte M. Comparison of the effectiveness of four bariatric surgery procedures in obese patients with type 2 diabetes: a retrospective study. J Obes. 2014;2014:638203.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Yip S, Plank LD, Murphy R. Gastric bypass and sleeve gastrectomy for type 2 diabetes: a systematic review and meta-analysis of outcomes. Obes Surg. 2013;23:1994–2003.

    Article  PubMed  Google Scholar 

  33. Zhang C, Yuan Y, Qiu C, et al. A meta-analysis of 2-year effect after surgery: laparoscopic Roux en Y gastric bypass versus laparoscopic sleeve gastrectomy for morbid obesity and diabetes mellitus. Obes Surg. 2014;24:1528–35.

    Article  PubMed  Google Scholar 

  34. Zhang Y, Wang J, Sun X, et al. Laparoscopic sleeve gastrectomy versus laparoscopic Roux en Y gastric bypass for morbid obesity and related comorbidities: a meta-analysis of 21 studies. Obese Surg. 2015;25:19.

    Article  Google Scholar 

  35. Lee WJ, Hur KY, Lakadawala M, et al. Gastrointestinal metabolic surgery for the treatment of diabetic patients: a multi-institutional intertnational study. J Gastrointest Surg. 2012;16:45–51.

    Google Scholar 

  36. Oman JJ, Nguyen SQ, Herron D. Comparison of comorbidity resolution and improvement between laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding. Surg Endosc. 2010;24:2513–7.

    Article  Google Scholar 

  37. Abbatini F, Rizzello M, Casella G. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24:1005–10.

    Article  PubMed  CAS  Google Scholar 

  38. Schauer PR, Bhatt DL, Kirwan J. Bariatric surgery versus intensive medical therapy for diabetes- 3 year outcomes. N Engl J Med. 2014;371(7):682.

    PubMed  CAS  Google Scholar 

  39. Iannelli A, Schneck AS, Topart P. Laparoscopic sleeve gastrectomy followed by duodenal switch in selected patients versus single-stage duodenal switch for superobesity: case-control study. Surg Obes Relat Dis. 2013;9(4):531–8.

    Article  PubMed  Google Scholar 

  40. Prachand VN, Ward M, Alverdy JC. Duodenal switch provides superior resolution of metabolic comorbidities independent of weight loss in the super-obese (BMI > 50kg/m2) compared with gastric bypass. J Gastrointest Surg. 2010;14:211–20.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gregg H. Jossart M.D., F.A.C.S. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Jossart, G.H. (2016). Sleeve Gastrectomy. In: Kurian, M., Wolfe, B., Ikramuddin, S. (eds) Metabolic Syndrome and Diabetes. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-3220-7_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-3220-7_12

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-3219-1

  • Online ISBN: 978-1-4939-3220-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics